Chiara Veronesi
Overview
Explore the profile of Chiara Veronesi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Degli Esposti L, Dovizio M, Perrone V, Veronesi C, Andretta M, Bacca M, et al.
Adv Ther
. 2023 Oct;
40(12):5338-5353.
PMID: 37787877
Introduction: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are rare autoimmune diseases triggering inflammation of small vessels. This real-world analysis was focused on the most common AAV forms, granulomatosis with polyangiitis...
12.
Ferreri A, Zinzani P, Messina C, Valsecchi D, Rendace M, Premoli E, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686679
This real-world analysis investigated patients with follicular lymphoma in Italy receiving three or more treatment lines (≥3L), focusing on therapeutic pathways with their rebounds on healthcare resource consumptions and costs....
13.
Antonini G, Habetswallner F, Inghilleri M, Mantegazza R, Rodolico C, Sacca F, et al.
Heliyon
. 2023 Jun;
9(6):e16367.
PMID: 37274644
The purpose of this study was to investigate the epidemiology, management, and economic burden of myasthenia gravis in settings of real clinical practice. The analysis used administrative databases covering around...
14.
Barbuto S, Perrone V, Veronesi C, Dovizio M, Zappulo F, Vetrano D, et al.
Nutrients
. 2023 Jan;
15(2).
PMID: 36678208
This real-world analysis evaluated the clinical and economic burden of non-dialysis-dependent CKD patients with and without secondary hyperparathyroidism (sHPT) in Italy. An observational retrospective study was conducted using administrative databases...
15.
Perrone V, Veronesi C, Giacomini E, Citraro R, DellOrco S, Lena F, et al.
Clin Epidemiol
. 2022 Nov;
14:1327-1337.
PMID: 36387930
Purpose: A retrospective analysis of real-world data was performed to assess the epidemiology and economic burden of multiple sclerosis (MS), relapsing-remitting MS (RRMS), and secondary-progressive MS (SPMS) in Italy. Patients...
16.
Perrone V, Veronesi C, Dovizio M, Ancona D, Bartolini F, Ferrante F, et al.
J Clin Med
. 2022 Oct;
11(19).
PMID: 36233688
Anaemia is a uraemia-related complication frequently found in non-dialysis-dependent chronic kidney disease (ND-CKD) patients, with iron-deficiency anaemia (IDA) as the main underlying mechanism. Given the suboptimal anaemia management in ND-CKD...
17.
Perrone V, Veronesi C, Dovizio M, Ancona D, Andretta M, Bartolini F, et al.
Clinicoecon Outcomes Res
. 2022 Aug;
14:513-521.
PMID: 35923519
Purpose: A retrospective analysis was conducted to estimate the number of patients with focal epilepsy and drug-resistant epilepsy (DRE) and their characteristics, the therapeutic patterns, the consumption of health resources...
18.
Perrone V, Dovizio M, Veronesi C, Andretta M, Bartolini F, Cavaliere A, et al.
Healthcare (Basel)
. 2022 Apr;
10(4).
PMID: 35455886
This Italian real-world data analysis evaluated the pharmaco-utilization of calcimimetics, cinacalcet or etelcalcetide, and the economic burden of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients. From 1 January...
19.
Degli Esposti L, Veronesi C, Ancona D, Andretta M, Bartolini F, Drei A, et al.
Clinicoecon Outcomes Res
. 2022 Mar;
14:139-147.
PMID: 35299992
Purpose: This real-world study investigates the direct healthcare costs from the perspective of the Italian Healthcare National Service of experienced statin users according to their level of adherence to therapy...
20.
Perrone V, Dovizio M, Veronesi C, Citraro R, De Francesco A, DellOrco S, et al.
Int J Environ Res Public Health
. 2022 Mar;
19(5).
PMID: 35270241
This Italian retrospective study aimed to analyze the pharmaco-utilization of anti-VEGF drugs and health care costs among patients with wet age-related macular degeneration (wAMD) or other ocular diseases. A retrospective...